X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with VST Industries - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VST INDUSTRIES - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

VST INDUSTRIES 
   Change

Incorporated in 1930, VST Industries is one of India's largest tobacco companies. The company began its operations under the name of Vazir Sultan and Sons, which was eventually changed to VST in 1983. The company's products include cigarettes, unmanu... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VST INDUSTRIES GSK CONSUMER/
VST INDUSTRIES
 
P/E (TTM) x 33.9 26.7 127.1% View Chart
P/BV x 9.1 12.0 75.6% View Chart
Dividend Yield % 1.3 2.4 54.6%  

Financials

 GSK CONSUMER   VST INDUSTRIES
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
VST INDUSTRIES
Mar-16
GSK CONSUMER/
VST INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs6,7711,846 366.8%   
Low Rs5,4481,400 389.1%   
Sales per share (Unadj.) Rs1,024.4572.0 179.1%  
Earnings per share (Unadj.) Rs163.399.2 164.7%  
Cash flow per share (Unadj.) Rs177.0119.3 148.4%  
Dividends per share (Unadj.) Rs70.0070.00 100.0%  
Dividend yield (eoy) %1.14.3 26.6%  
Book value per share (Unadj.) Rs581.5239.9 242.4%  
Shares outstanding (eoy) m42.0615.44 272.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.02.8 210.2%   
Avg P/E ratio x37.416.4 228.6%  
P/CF ratio (eoy) x34.513.6 253.7%  
Price / Book Value ratio x10.56.8 155.3%  
Dividend payout %42.970.6 60.7%   
Avg Mkt Cap Rs m256,95925,058 1,025.5%   
No. of employees `0003.70.8 452.2%   
Total wages/salary Rs m5,094804 634.0%   
Avg. sales/employee Rs Th11,548.510,704.9 107.9%   
Avg. wages/employee Rs Th1,365.3973.9 140.2%   
Avg. net profit/employee Rs Th1,841.11,855.9 99.2%   
INCOME DATA
Net Sales Rs m43,0878,832 487.9%  
Other income Rs m2,788202 1,380.0%   
Total revenues Rs m45,8759,034 507.8%   
Gross profit Rs m8,3492,374 351.7%  
Depreciation Rs m574310 185.2%   
Interest Rs m80-   
Profit before tax Rs m10,5542,266 465.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,685735 501.5%   
Profit after tax Rs m6,8691,531 448.6%  
Gross profit margin %19.426.9 72.1%  
Effective tax rate %34.932.4 107.7%   
Net profit margin %15.917.3 92.0%  
BALANCE SHEET DATA
Current assets Rs m37,5605,842 642.9%   
Current liabilities Rs m18,1534,474 405.8%   
Net working cap to sales %45.015.5 290.7%  
Current ratio x2.11.3 158.4%  
Inventory Days Days39156 25.1%  
Debtors Days Days305 586.4%  
Net fixed assets Rs m5,3742,147 250.3%   
Share capital Rs m421154 272.4%   
"Free" reserves Rs m24,0033,516 682.6%   
Net worth Rs m24,4563,704 660.2%   
Long term debt Rs m00-   
Total assets Rs m44,9888,271 543.9%  
Interest coverage x1,336.9NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.01.1 89.7%   
Return on assets %15.318.5 82.6%  
Return on equity %28.141.3 68.0%  
Return on capital %43.261.2 70.6%  
Exports to sales %5.121.1 24.3%   
Imports to sales %0.45.3 7.3%   
Exports (fob) Rs m2,2111,862 118.7%   
Imports (cif) Rs m168470 35.7%   
Fx inflow Rs m2,8161,862 151.2%   
Fx outflow Rs m261826 31.5%   
Net fx Rs m2,5551,037 246.5%   
CASH FLOW
From Operations Rs m5,7241,321 433.2%  
From Investments Rs m-1,569-240 655.0%  
From Financial Activity Rs m-2,792-1,301 214.6%  
Net Cashflow Rs m1,363-219 -621.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 72.5 32.2 225.2%  
Indian inst/Mut Fund % 0.8 14.3 5.6%  
FIIs % 12.0 11.9 100.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 41.7 35.5%  
Shareholders   26,457 13,157 201.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   SANWARIA AGRO OILS  DABUR  RUCHI SOYA INDUSTRIES  KRBL LIMITED  AVANTI FEEDS  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 17, 2017 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS